Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Learn why MiniMed Flex insulin pumps were recalled, the potential insulin delivery risks, and what affected users should do to stay safe.
Read More »This Insulin Pump Recall Could Affect More Than Convenience
After DKA or Repeated Low Blood Sugar, Could Attention Problems Linger?
Explore how hypoglycemia and DKA may be linked to attention difficulties in children with type 1 diabetes and what new research reveals.
Read More »Could Fenofibrate Slow Diabetic Eye Disease in Type 1 Diabetes?
Can fenofibrate slow diabetic retinopathy in type 1 diabetes? Explore new LENS trial research, potential benefits, safety, and clinical implications.
Read More »Type 1 Diabetes Care Just Changed: The 2026 ADA/EASD Update Clinicians Need to Know
The type 1 diabetes consensus 2026 expands guidance on AID, cardiovascular risk, obesity, complications, psychosocial care, and new therapies.
Read More »Pump or Smart Pen? A Head-to-Head Trial Finds There May Be More Than One Right Answer
A head-to-head trial compared a smart insulin pen vs AID in adults with type 1 diabetes. See who benefited most and why patient preference still matters.
Read More »Sex and Blood Sugar: Does Intimacy Put People With Type 1 Diabetes at Risk for Hypoglycemia?
A small CGM study explores whether sexual activity increases hypoglycemia risk in adults with type 1 diabetes and what the findings mean for care.
Read More »Fasting With Type 1 Diabetes? A New Trial Puts Time-Restricted Eating to the Test
Time-restricted eating has become a popular approach to weight management, but what happens when insulin-dependent diabetes enters the picture? Until recently, evidence on time-restricted eating in people with type 1 diabetes was notably limited. A new randomized controlled trial published in Diabetes Care offers some of the first direct evidence. …
Read More »Could CGM Help People With Type 1 Diabetes Live Longer?
Could continuous glucose monitoring do more than improve glucose levels and help prevent hypoglycemia? New research raises that possibility. A large observational study examining CGM use and mortality in people with type 1 diabetes found that starting continuous glucose monitoring was associated with a lower risk of death among older …
Read More »When “Normal” Blood Sugar Feels Too Low: New Research May Explain Why
When glucose numbers improve, patients are expected to feel better. Yet some people with type 1 diabetes report the opposite. A glucose level that looks reassuring on a continuous glucose monitor may leave them feeling tired, uncomfortable, or simply “off.” New research suggests that glycemic habituation may help explain this …
Read More »SGLT Inhibitors Protect the Heart and Kidneys: Why Is Type 1 Diabetes Still the Exception?
SGLT inhibitors have changed the treatment landscape for cardiovascular and kidney disease, particularly in people with type 2 diabetes, heart failure, and chronic kidney disease. That success raises an obvious question: why are SGLT inhibitors in type 1 diabetes still largely outside routine clinical practice? The answer is not a …
Read More »